Skip to main content
SIR: Dementia with Lewy bodies (DLB) is a lately identified concept based on a clinical and pathological correlation: progressive disabling mental impairment with peculiar features such as hallucinations, fluctuating cognition or motor parkinsonism, and cortical with or without subcortical Lewy bodies.1 We report briefly two cases with unusual features of DLB.

Case Reports

Case 1. A 74-year-old woman with no significant medical history but with depression 1 year ago began complaining of slowness of movements. Examination disclosed mild features of parkinsonism, including reduced armswing, rigidity, and bradykinesia, without resting tremor. Mini-Mental State Examination (MMSE) score was 30/30. Shortly after low doses of levodopa (150 mg) were given, parkinsonian features receded, but visual complex hallucinations arose. These hallucinations were not recognized as unreal and even worsened after levodopa was stopped or clozapine was given. Cognitive impairment appeared 7 months later. Hospitalization then occurred as myoclonus became evident. MMSE was 6/30, with perseveration and rigid-akinetic signs at examination. Decline was markedly rapid, and the patient died 8 months after the onset of the symptoms. Brain computed tomography (CT) revealed cerebral atrophy. EEG showed triphasic complexes without periodicity. 14-3-3 protein was not detected in the cerebrospinal fluid (CSF). Diffuse cortical Lewy bodies were found at autopsy.
Case 2. A 72-year-old man with history of tobacco addiction and asbestosis presented with a 1-year history of progressive forgetfulness. Examination disclosed mild temporospatial confusion, dressing and ideomotor apraxia, and bilateral cogwheel rigidity. Language and attention were well preserved. Brain CT was normal. Six months later, the patient came to the hospital for cognitive impairment with shuffling gait. Examination showed akinesia and rigidity. MMSE was 9/30. Routine biological investigations were unrevealing, with no changes on brain CT. EEG showed slow left activities. Four months later, the patient was admitted to the hospital bedridden in the course of continuous and progressive decline. He was alert but unresponsive to voice. Examination disclosed rest myoclonus increased by noise, with no pyramidal features or focal signs. There was biological evidence of dehydration, with elevated natremia and creatinemia. CSF was germ-free, without pleocytosis. EEG showed slow delta activity without periodic discharges. The patient died 5 days after admission. Autopsy disclosed numerous senile plaques, neurofibrillary tangles, and cortical and subcortical Lewy bodies without spongiform changes.

Comment

Both of these case reports are of particular interest because the patients evolved very rapidly to a fatal outcome (8 and 22 months) and had myoclonus in the late stage. Mean duration of DLB ranges from 5 to 8 years,2 although a 22-month duration has been described.3 Myoclonus is uncommon in DLB and was not mentioned in the first clinical descriptions.4,5 Although not excluded, it is not a feature essential to or supportive of the diagnosis of DLB.1 Myoclonus in patients with a rapidly progressive form of dementia raises the suspicion of Creutzfeldt-Jacob disease. Once a prion disease is ruled out, DLB should be considered in such patients.

References

1.
McKeith IG, Galasko D, Kosaka K et al: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47:1113–1124
2.
Gomez-Tortosa E, Ingraham AO, Irizarry MC, et al: Dementia with Lewy bodies. J Am Geriatr Soc 1998; 46:1449–1458
3.
Litvan I, McKee A: Clinicopathologic case report: dementia with Lewy bodies (DLB). J Neuropsychiatry Clin Neurosci 1999; 11:107–112
4.
Ala TA, Yang KH, Sung JH, et al: Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study. J Neurol Neurosurg Psychiatry 1997; 62:16–21
5.
Kosaka K: Diffuse Lewy body disease in Japan. J Neurol 1990; 237:197–204

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 412
PubMed: 10956579

History

Published online: 1 August 2000
Published in print: August 2000

Authors

Affiliations

Michel Bregigeon, M.D.
Christian Brosset, M.D.
Hôpital Laveran, Marseille, France
Jean Louis Kemeny, M.D.
Pierre Clavelou, M.D.
Hôpital Frontmaure, Chamalières, France
Jean Francois Pellissier, M.D.
Hôpital de la Timone, Marseille, France

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share